tandutinib
Date：2021-12-08 Categories：Related Application Product
| Post Date: |
Dec 07,2021 |
| Expiry Date: |
Jun 05,2022 |
| Detailed Description: |
Cas No. :387867-13-2
tandutinib
387867-13-2 |
| CAS Registry Number: |
387867-13-2
|
| Synonyms: |
;Tandutinib;Tandutinib(TINIBS);(4-(6-Methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl)piperazinyl)-N-(4-(methylethoxy)phenyl)carboxamide;4-[6-Methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl]-N-[4-(1-methylethoxy)phenyl]-1-piperazinecarboxamide;CT 53518;MLN 518;4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-[4-(1-methylethoxy)phenyl]piperazine-1-carboxamide; |
| Molecular Formula: |
C31H42N6O4 |
| Molecular Weight: |
562.703 |
| Molecular Structure: |
![387867-13-2 4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide](https://www.morpholine.org/wp-content/uploads/cas387867-13-2.gif)
|
